Literature DB >> 21873525

Virus-specific CD8+ T cells upregulate programmed death-1 expression during acute friend retrovirus infection but are highly cytotoxic and control virus replication.

Gennadiy Zelinskyy1, Lara Myers, Kirsten K Dietze, Kathrin Gibbert, Michael Roggendorf, Jia Liu, Mengji Lu, Anke R Kraft, Volker Teichgräber, Kim J Hasenkrug, Ulf Dittmer.   

Abstract

It was recently reported that inhibitory molecules such as programmed death-1 (PD-1) were upregulated on CD8(+) T cells during acute Friend retrovirus infection and that the cells were prematurely exhausted and dysfunctional in vitro. The current study confirms that most activated CD8(+) T cells upregulated expression of PD-1 during acute infection and revealed a dichotomy of function between PD-1(hi) and PD-1(lo) subsets. More PD-1(lo) cells produced antiviral cytokines such as IFN-γ and TNF-α, whereas more PD-1(hi) cells displayed characteristics of cytotoxic effectors such as production of granzymes and surface expression of CD107a. Importantly, CD8(+) T cells mediated rapid in vivo cytotoxicity and were critical for control of acute Friend virus replication. Thus, direct ex vivo analyses and in vivo experiments revealed high CD8(+) T cell functionality and indicate that PD-1 expression during acute infection is not a marker of T cell exhaustion.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21873525      PMCID: PMC3402334          DOI: 10.4049/jimmunol.1101612

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

1.  Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells.

Authors:  Ana C Anderson; David E Anderson; Lisa Bregoli; William D Hastings; Nasim Kassam; Charles Lei; Rucha Chandwaskar; Jozsef Karman; Ee W Su; Mitsuomi Hirashima; Jeffrey N Bruce; Lawrence P Kane; Vijay K Kuchroo; David A Hafler
Journal:  Science       Date:  2007-11-16       Impact factor: 47.728

2.  Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.

Authors:  Zheng Zhang; Ji-Yuan Zhang; E John Wherry; Bo Jin; Bin Xu; Zheng-Sheng Zou; Shu-Ye Zhang; Bao-Sen Li; Hui-Feng Wang; Hao Wu; George K K Lau; Yang-Xin Fu; Fu-Sheng Wang
Journal:  Gastroenterology       Date:  2008-03-22       Impact factor: 22.682

3.  Suppression of acute anti-friend virus CD8+ T-cell responses by coinfection with lactate dehydrogenase-elevating virus.

Authors:  Shelly J Robertson; Christoph G Ammann; Ronald J Messer; Aaron B Carmody; Lara Myers; Ulf Dittmer; Savita Nair; Nicole Gerlach; Leonard H Evans; William A Cafruny; Kim J Hasenkrug
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

4.  High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome.

Authors:  Victoria Kasprowicz; Julian Schulze Zur Wiesch; Thomas Kuntzen; Brian E Nolan; Steven Longworth; Andrew Berical; Jenna Blum; Cory McMahon; Laura L Reyor; Nahel Elias; William W Kwok; Barbara G McGovern; Gordon Freeman; Raymond T Chung; Paul Klenerman; Lia Lewis-Ximenez; Bruce D Walker; Todd M Allen; Arthur Y Kim; Georg M Lauer
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

5.  The programmed death-1 and interleukin-10 pathways play a down-modulatory role in LP-BM5 retrovirus-induced murine immunodeficiency syndrome.

Authors:  Kathy A Green; Taku Okazaki; Tasuku Honjo; W James Cook; William R Green
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

6.  Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction.

Authors:  Lucy Golden-Mason; Brent Palmer; Jared Klarquist; John A Mengshol; Nicole Castelblanco; Hugo R Rosen
Journal:  J Virol       Date:  2007-06-13       Impact factor: 5.103

7.  PDL-1 blockade impedes T cell expansion and protective immunity primed by attenuated Listeria monocytogenes.

Authors:  Jared H Rowe; Tanner M Johanns; James M Ertelt; Sing Sing Way
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

8.  Detrimental contribution of the immuno-inhibitor B7-H1 to rabies virus encephalitis.

Authors:  Monique Lafon; Françoise Mégret; Sven G Meuth; Ole Simon; Myriam L Velandia Romero; Mireille Lafage; Lieping Chen; Lena Alexopoulou; Richard A Flavell; Christophe Prehaud; Heinz Wiendl
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

9.  Differential kinetics of antigen-specific CD4+ and CD8+ T cell responses in the regression of retrovirus-induced sarcomas.

Authors:  Koen Schepers; Mireille Toebes; Gitte Sotthewes; Florry A Vyth-Dreese; Trees A M Dellemijn; Cornelis J M Melief; Ferry Ossendorp; Ton N M Schumacher
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

10.  Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates.

Authors:  Surojit Sarkar; Vandana Kalia; W Nicholas Haining; Bogumila T Konieczny; Shruti Subramaniam; Rafi Ahmed
Journal:  J Exp Med       Date:  2008-03-03       Impact factor: 14.307

View more
  46 in total

1.  Local blockade of epithelial PDL-1 in the airways enhances T cell function and viral clearance during influenza virus infection.

Authors:  Beth McNally; Fang Ye; Meredith Willette; Emilio Flaño
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

2.  Programmed death-1 controls T cell survival by regulating oxidative metabolism.

Authors:  Victor Tkachev; Stefanie Goodell; Anthony W Opipari; Ling-Yang Hao; Luigi Franchi; Gary D Glick; James L M Ferrara; Craig A Byersdorfer
Journal:  J Immunol       Date:  2015-05-13       Impact factor: 5.422

3.  T cell differentiation in chronic infection and cancer: functional adaptation or exhaustion?

Authors:  Daniel E Speiser; Daniel T Utzschneider; Susanne G Oberle; Christian Münz; Pedro Romero; Dietmar Zehn
Journal:  Nat Rev Immunol       Date:  2014-09-26       Impact factor: 53.106

4.  CD8+ T cells are essential for controlling acute friend retrovirus infection in C57BL/6 mice.

Authors:  Jara J Joedicke; Gennadiy Zelinskyy; Ulf Dittmer; Kim J Hasenkrug
Journal:  J Virol       Date:  2014-05       Impact factor: 5.103

5.  Reply to "CD8+ T cells are essential for controlling acute friend virus infection in C57BL/6 mice".

Authors:  Sachiyo Tsuji-Kawahara; Shiki Takamura; Masaaki Miyazawa
Journal:  J Virol       Date:  2014-05       Impact factor: 5.103

6.  Myeloid-derived suppressor cells in murine retrovirus-induced AIDS inhibit T- and B-cell responses in vitro that are used to define the immunodeficiency.

Authors:  Kathy A Green; W James Cook; William R Green
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

7.  Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection.

Authors:  Jeffrey E Teigler; Gennadiy Zelinskyy; Michael A Eller; Diane L Bolton; Mary Marovich; Alexander D Gordon; Aljawharah Alrubayyi; Galit Alter; Merlin L Robb; Jeffrey N Martin; Steven G Deeks; Nelson L Michael; Ulf Dittmer; Hendrik Streeck
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

8.  Activated CD8+ T cells induce expansion of Vβ5+ regulatory T cells via TNFR2 signaling.

Authors:  Jara J Joedicke; Lara Myers; Aaron B Carmody; Ronald J Messer; Harald Wajant; Karl S Lang; Philipp A Lang; Tak W Mak; Kim J Hasenkrug; Ulf Dittmer
Journal:  J Immunol       Date:  2014-08-06       Impact factor: 5.422

9.  Selective Involvement of the Checkpoint Regulator VISTA in Suppression of B-Cell, but Not T-Cell, Responsiveness by Monocytic Myeloid-Derived Suppressor Cells from Mice Infected with an Immunodeficiency-Causing Retrovirus.

Authors:  Kathy A Green; Li Wang; Randolph J Noelle; William R Green
Journal:  J Virol       Date:  2015-07-08       Impact factor: 5.103

10.  Association Between Imaging Findings of Airway Obstruction Adjacent to Lung Tumors and the Onset of Interstitial Lung Disease After Nivolumab.

Authors:  Kenji Nakahama; Akihiro Tamiya; Shun-Ichi Isa; Yoshihiko Taniguchi; Takayuki Shiroyama; Hidekazu Suzuki; Takako Inoue; Motohiro Tamiya; Tomonori Hirashima; Fumio Imamura; Shinji Atagi
Journal:  In Vivo       Date:  2018 Jul-Aug       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.